Wells Fargo & Company Bristol Myers Squibb CO Put Options Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $3.18 Million - $3.61 Million	-66,300 Reduced 92.99%	5,000 $271,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $13.1 Million - $15.6 Million	-270,000 Reduced 79.11%	71,300 $3.66 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $9.07 Million - $10.1 Million	-156,600 Reduced 31.45%	341,300 $19.8 Million
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $9.75 Million - $10.8 Million	153,100 Added 44.4%	497,900 $31.8 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $7.74 Million - $8.78 Million	-117,800 Reduced 25.46%	344,800 $23.9 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $178,048 - $210,834	2,600 Added 0.57%	462,600 $33.3 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $19.2 Million - $23 Million	312,400 Added 211.65%	460,000 $33.6 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $19.9 Million - $22.4 Million	-335,000 Reduced 69.42%	147,600 $9.32 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $3.47 Million - $3.93 Million	-60,100 Reduced 11.07%	482,600 $363,000
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $1.15 Million - $1.27 Million	20,000 Added 3.83%	542,700 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $2.97 Million - $3.47 Million	54,100 Added 11.55%	522,700 $2.55 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $21.7 Million - $31.6 Million	468,600 New	468,600 $3.16 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.